Global Nano Biotechnology Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Nano Biotechnology Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 104

Published Date: 12 Jan 2023

Category: New Technology

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The Nano Biotechnology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Nano Biotechnology market size will reach USD million in 2029, growing at a CAGR of % over the analysis period.

Market segmentation
Nano Biotechnology market is split by Type and by Application. For the period 2023-2029, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
0-10 nm
10-100 nm

Market segment by Application, can be divided into
Pharmaceuticals
Medical Devices
Medical Research
Other

Market segment by players, this report covers
Aduro BioTech
Calando Pharmaceuticals
Biosante Phosphate Pharmaceuticals
Celgene Corporation
Elan Pharmaceuticals
Flamel Technologies
Nanophase Technologies
Sigma Aldrich Company
Dendritic Nanotechnologies
SkyePharma Pharmaceuticals

Market segment by regions, regional analysis covers
North America
Europe
Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
South America
Middle East & Africa

The content of the study subjects, includes a total of 8 chapters:
Chapter 1, to describe Nano Biotechnology product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Nano Biotechnology, with recent developments and future plans
Chapter 3, the Nano Biotechnology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4, to break the market size data at the region level, with key companies in the key region and Nano Biotechnology market forecast, by regions, with revenue, from 2023 to 2029.
Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2023 to 2029.
Chapter 7 and 8, to describe Nano Biotechnology research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Nano Biotechnology
1.2 Classification of Nano Biotechnology by Type
1.2.1 Overview: Global Nano Biotechnology Market Size by Type: 2022 Versus 2028
1.2.2 Global Nano Biotechnology Revenue Market Share by Type in 2029
1.2.3 0-10 nm
1.2.4 10-100 nm
1.3 Global Nano Biotechnology Market by Application
1.3.1 Overview: Global Nano Biotechnology Market Size by Application: 2023 Versus 2029
1.3.2 Pharmaceuticals
1.3.3 Medical Devices
1.3.4 Medical Research
1.3.5 Other
1.4 Global Nano Biotechnology Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
1.5.1 Nano Biotechnology Market Drivers
1.5.2 Nano Biotechnology Market Restraints
1.5.3 Nano Biotechnology Trends Analysis

2 Company Profiles
2.1 Aduro BioTech
2.1.1 Aduro BioTech Details
2.1.2 Aduro BioTech Major Business
2.1.3 Aduro BioTech Nano Biotechnology Product and Solutions
2.1.4 Aduro BioTech Recent Developments and Future Plans
2.2 Calando Pharmaceuticals
2.2.1 Calando Pharmaceuticals Details
2.2.2 Calando Pharmaceuticals Major Business
2.2.3 Calando Pharmaceuticals Nano Biotechnology Product and Solutions
2.2.4 Calando Pharmaceuticals Recent Developments and Future Plans
2.3 Biosante Phosphate Pharmaceuticals
2.3.1 Biosante Phosphate Pharmaceuticals Details
2.3.2 Biosante Phosphate Pharmaceuticals Major Business
2.3.3 Biosante Phosphate Pharmaceuticals Nano Biotechnology Product and Solutions
2.3.4 Biosante Phosphate Pharmaceuticals Recent Developments and Future Plans
2.4 Celgene Corporation
2.4.1 Celgene Corporation Details
2.4.2 Celgene Corporation Major Business
2.4.3 Celgene Corporation Nano Biotechnology Product and Solutions
2.4.4 Celgene Corporation Recent Developments and Future Plans
2.5 Elan Pharmaceuticals
2.5.1 Elan Pharmaceuticals Details
2.5.2 Elan Pharmaceuticals Major Business
2.5.3 Elan Pharmaceuticals Nano Biotechnology Product and Solutions
2.5.4 Elan Pharmaceuticals Recent Developments and Future Plans
2.6 Flamel Technologies
2.6.1 Flamel Technologies Details
2.6.2 Flamel Technologies Major Business
2.6.3 Flamel Technologies Nano Biotechnology Product and Solutions
2.6.4 Flamel Technologies Recent Developments and Future Plans
2.7 Nanophase Technologies
2.7.1 Nanophase Technologies Details
2.7.2 Nanophase Technologies Major Business
2.7.3 Nanophase Technologies Nano Biotechnology Product and Solutions
2.7.4 Nanophase Technologies Recent Developments and Future Plans
2.8 Sigma Aldrich Company
2.8.1 Sigma Aldrich Company Details
2.8.2 Sigma Aldrich Company Major Business
2.8.3 Sigma Aldrich Company Nano Biotechnology Product and Solutions
2.8.4 Sigma Aldrich Company Recent Developments and Future Plans
2.9 Dendritic Nanotechnologies
2.9.1 Dendritic Nanotechnologies Details
2.9.2 Dendritic Nanotechnologies Major Business
2.9.3 Dendritic Nanotechnologies Nano Biotechnology Product and Solutions
2.9.4 Dendritic Nanotechnologies Recent Developments and Future Plans
2.10 SkyePharma Pharmaceuticals
2.10.1 SkyePharma Pharmaceuticals Details
2.10.2 SkyePharma Pharmaceuticals Major Business
2.10.3 SkyePharma Pharmaceuticals Nano Biotechnology Product and Solutions
2.10.4 SkyePharma Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Nano Biotechnology Revenue and Share by Players (2023 & 2029)
3.2 Nano Biotechnology Players Head Office, Products and Services Provided
3.3 Nano Biotechnology Mergers & Acquisitions
3.4 Nano Biotechnology New Entrants and Expansion Plans

4 Global Nano Biotechnology Forecast by Region
4.1 Global Nano Biotechnology Market Size by Region: 2023 VS 2029
4.2 Global Nano Biotechnology Market Size by Region, (2023-2029)
4.3 North America
4.3.1 Key Companies of Nano Biotechnology in North America
4.3.2 Current Situation and Forecast of Nano Biotechnology in North America
4.3.3 North America Nano Biotechnology Market Size and Prospect (2023-2029)
4.4 Europe
4.4.1 Key Companies of Nano Biotechnology in Europe
4.4.2 Current Situation and Forecast of Nano Biotechnology in Europe
4.4.3 Europe Nano Biotechnology Market Size and Prospect (2023-2029)
4.5 Asia-Pacific
4.5.1 Key Companies of Nano Biotechnology in Asia-Pacific
4.5.2 Current Situation and Forecast of Nano Biotechnology in Asia-Pacific
4.5.3 Asia-Pacific Nano Biotechnology Market Size and Prospect (2023-2029)
4.5.4 China
4.5.5 Japan
4.5.6 South Korea
4.6 South America
4.6.1 Key Companies of Nano Biotechnology in South America
4.6.2 Current Situation and Forecast of Nano Biotechnology in South America
4.6.3 South America Nano Biotechnology Market Size and Prospect (2023-2029)
4.7 Middle East & Africa
4.7.1 Key Companies of Nano Biotechnology in Middle East & Africa
4.7.2 Current Situation and Forecast of Nano Biotechnology in Middle East & Africa
4.7.3 Middle East & Africa Nano Biotechnology Market Size and Prospect (2023-2029)

5 Market Size Segment by Type
5.1 Global Nano Biotechnology Market Forecast by Type (2023-2029)
5.2 Global Nano Biotechnology Market Share Forecast by Type (2023-2029)

6 Market Size Segment by Application
6.1 Global Nano Biotechnology Market Forecast by Application (2023-2029)
6.2 Global Nano Biotechnology Market Share Forecast by Application (2023-2029)

7 Research Findings and Conclusion

8 Appendix
8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Nano Biotechnology Revenue by Type, (USD Million), 2023 VS 2029
Table 2. Global Nano Biotechnology Revenue by Application, (USD Million), 2023 VS 2029
Table 3. Aduro BioTech Corporate Information, Head Office, and Major Competitors
Table 4. Aduro BioTech Major Business
Table 5. Aduro BioTech Nano Biotechnology Product and Solutions
Table 6. Calando Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 7. Calando Pharmaceuticals Major Business
Table 8. Calando Pharmaceuticals Nano Biotechnology Product and Solutions
Table 9. Biosante Phosphate Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 10. Biosante Phosphate Pharmaceuticals Major Business
Table 11. Biosante Phosphate Pharmaceuticals Nano Biotechnology Product and Solutions
Table 12. Celgene Corporation Corporate Information, Head Office, and Major Competitors
Table 13. Celgene Corporation Major Business
Table 14. Celgene Corporation Nano Biotechnology Product and Solutions
Table 15. Elan Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 16. Elan Pharmaceuticals Major Business
Table 17. Elan Pharmaceuticals Nano Biotechnology Product and Solutions
Table 18. Flamel Technologies Corporate Information, Head Office, and Major Competitors
Table 19. Flamel Technologies Major Business
Table 20. Flamel Technologies Nano Biotechnology Product and Solutions
Table 21. Nanophase Technologies Corporate Information, Head Office, and Major Competitors
Table 22. Nanophase Technologies Major Business
Table 23. Nanophase Technologies Nano Biotechnology Product and Solutions
Table 24. Sigma Aldrich Company Corporate Information, Head Office, and Major Competitors
Table 25. Sigma Aldrich Company Major Business
Table 26. Sigma Aldrich Company Nano Biotechnology Product and Solutions
Table 27. Dendritic Nanotechnologies Corporate Information, Head Office, and Major Competitors
Table 28. Dendritic Nanotechnologies Major Business
Table 29. Dendritic Nanotechnologies Nano Biotechnology Product and Solutions
Table 30. SkyePharma Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 31. SkyePharma Pharmaceuticals Major Business
Table 32. SkyePharma Pharmaceuticals Nano Biotechnology Product and Solutions
Table 33. Global Nano Biotechnology Revenue (USD Million) by Players (2023 & 2029)
Table 34. Global Nano Biotechnology Revenue Share by Players (2023 & 2029)
Table 35. Nano Biotechnology Players Head Office, Products and Services Provided
Table 36. Nano Biotechnology Mergers & Acquisitions in the Past Five Years
Table 37. Nano Biotechnology New Entrants and Expansion Plans
Table 38. Global Market Nano Biotechnology Revenue (USD Million) Comparison by Region (2023 VS 2029)
Table 39. Global Nano Biotechnology Revenue Market Share by Region (2023-2029)
Table 40. Key Companies of Nano Biotechnology in North America
Table 41. Current Situation and Forecast of Nano Biotechnology in North America
Table 42. Key Companies of Nano Biotechnology in Europe
Table 43. Current Situation and Forecast of Nano Biotechnology in Europe
Table 44. Key Companies of Nano Biotechnology in Asia-Pacific
Table 45. Current Situation and Forecast of Nano Biotechnology in Asia-Pacific
Table 46. Key Companies of Nano Biotechnology in China
Table 47. Key Companies of Nano Biotechnology in Japan
Table 48. Key Companies of Nano Biotechnology in South Korea
Table 49. Key Companies of Nano Biotechnology in South America
Table 50. Current Situation and Forecast of Nano Biotechnology in South America
Table 51. Key Companies of Nano Biotechnology in Middle East & Africa
Table 52. Current Situation and Forecast of Nano Biotechnology in Middle East & Africa
Table 53. Global Nano Biotechnology Revenue Forecast by Type (2023-2029)
Table 54. Global Nano Biotechnology Revenue Forecast by Application (2023-2029)
List of Figures
Figure 1. Nano Biotechnology Picture
Figure 2. Global Nano Biotechnology Revenue Market Share by Type in 2029
Figure 3. 0-10 nm
Figure 4. 10-100 nm
Figure 5. Nano Biotechnology Revenue Market Share by Application in 2029
Figure 6. Pharmaceuticals Picture
Figure 7. Medical Devices Picture
Figure 8. Medical Research Picture
Figure 9. Other Picture
Figure 10. Global Nano Biotechnology Market Size, (USD Million): 2023 VS 2029
Figure 11. Global Nano Biotechnology Revenue and Forecast (2023-2029) & (USD Million)
Figure 12. Nano Biotechnology Market Drivers
Figure 13. Nano Biotechnology Market Restraints
Figure 14. Nano Biotechnology Market Trends
Figure 15. Aduro BioTech Recent Developments and Future Plans
Figure 16. Calando Pharmaceuticals Recent Developments and Future Plans
Figure 17. Biosante Phosphate Pharmaceuticals Recent Developments and Future Plans
Figure 18. Celgene Corporation Recent Developments and Future Plans
Figure 19. Elan Pharmaceuticals Recent Developments and Future Plans
Figure 20. Flamel Technologies Recent Developments and Future Plans
Figure 21. Nanophase Technologies Recent Developments and Future Plans
Figure 22. Sigma Aldrich Company Recent Developments and Future Plans
Figure 23. Dendritic Nanotechnologies Recent Developments and Future Plans
Figure 24. SkyePharma Pharmaceuticals Recent Developments and Future Plans
Figure 25. Global Nano Biotechnology Revenue Market Share by Region (2023-2029)
Figure 26. Global Nano Biotechnology Revenue Market Share by Region in 2029
Figure 27. North America Nano Biotechnology Revenue (USD Million) and Growth Rate (2023-2029)
Figure 28. Europe Nano Biotechnology Revenue (USD Million) and Growth Rate (2023-2029)
Figure 29. Asia-Pacific Nano Biotechnology Revenue (USD Million) and Growth Rate (2023-2029)
Figure 30. South America Nano Biotechnology Revenue (USD Million) and Growth Rate (2023-2029)
Figure 31. Middle East & Africa Nano Biotechnology Revenue (USD Million) and Growth Rate (2023-2029)
Figure 32. Global Nano Biotechnology Market Share Forecast by Type (2023-2029)
Figure 33. Global Nano Biotechnology Market Share Forecast by Application (2023-2029)
Figure 34. Methodology
Figure 35. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Aduro BioTech
Calando Pharmaceuticals
Biosante Phosphate Pharmaceuticals
Celgene Corporation
Elan Pharmaceuticals
Flamel Technologies
Nanophase Technologies
Sigma Aldrich Company
Dendritic Nanotechnologies
SkyePharma Pharmaceuticals
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Nano Biotechnology Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Nano Biotechnology Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 104

Published Date: 12 Jan 2023

Category: New Technology

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The Nano Biotechnology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Nano Biotechnology market size will reach USD million in 2029, growing at a CAGR of % over the analysis period.

Market segmentation
Nano Biotechnology market is split by Type and by Application. For the period 2023-2029, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
0-10 nm
10-100 nm

Market segment by Application, can be divided into
Pharmaceuticals
Medical Devices
Medical Research
Other

Market segment by players, this report covers
Aduro BioTech
Calando Pharmaceuticals
Biosante Phosphate Pharmaceuticals
Celgene Corporation
Elan Pharmaceuticals
Flamel Technologies
Nanophase Technologies
Sigma Aldrich Company
Dendritic Nanotechnologies
SkyePharma Pharmaceuticals

Market segment by regions, regional analysis covers
North America
Europe
Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
South America
Middle East & Africa

The content of the study subjects, includes a total of 8 chapters:
Chapter 1, to describe Nano Biotechnology product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Nano Biotechnology, with recent developments and future plans
Chapter 3, the Nano Biotechnology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4, to break the market size data at the region level, with key companies in the key region and Nano Biotechnology market forecast, by regions, with revenue, from 2023 to 2029.
Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2023 to 2029.
Chapter 7 and 8, to describe Nano Biotechnology research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Nano Biotechnology
1.2 Classification of Nano Biotechnology by Type
1.2.1 Overview: Global Nano Biotechnology Market Size by Type: 2022 Versus 2028
1.2.2 Global Nano Biotechnology Revenue Market Share by Type in 2029
1.2.3 0-10 nm
1.2.4 10-100 nm
1.3 Global Nano Biotechnology Market by Application
1.3.1 Overview: Global Nano Biotechnology Market Size by Application: 2023 Versus 2029
1.3.2 Pharmaceuticals
1.3.3 Medical Devices
1.3.4 Medical Research
1.3.5 Other
1.4 Global Nano Biotechnology Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
1.5.1 Nano Biotechnology Market Drivers
1.5.2 Nano Biotechnology Market Restraints
1.5.3 Nano Biotechnology Trends Analysis

2 Company Profiles
2.1 Aduro BioTech
2.1.1 Aduro BioTech Details
2.1.2 Aduro BioTech Major Business
2.1.3 Aduro BioTech Nano Biotechnology Product and Solutions
2.1.4 Aduro BioTech Recent Developments and Future Plans
2.2 Calando Pharmaceuticals
2.2.1 Calando Pharmaceuticals Details
2.2.2 Calando Pharmaceuticals Major Business
2.2.3 Calando Pharmaceuticals Nano Biotechnology Product and Solutions
2.2.4 Calando Pharmaceuticals Recent Developments and Future Plans
2.3 Biosante Phosphate Pharmaceuticals
2.3.1 Biosante Phosphate Pharmaceuticals Details
2.3.2 Biosante Phosphate Pharmaceuticals Major Business
2.3.3 Biosante Phosphate Pharmaceuticals Nano Biotechnology Product and Solutions
2.3.4 Biosante Phosphate Pharmaceuticals Recent Developments and Future Plans
2.4 Celgene Corporation
2.4.1 Celgene Corporation Details
2.4.2 Celgene Corporation Major Business
2.4.3 Celgene Corporation Nano Biotechnology Product and Solutions
2.4.4 Celgene Corporation Recent Developments and Future Plans
2.5 Elan Pharmaceuticals
2.5.1 Elan Pharmaceuticals Details
2.5.2 Elan Pharmaceuticals Major Business
2.5.3 Elan Pharmaceuticals Nano Biotechnology Product and Solutions
2.5.4 Elan Pharmaceuticals Recent Developments and Future Plans
2.6 Flamel Technologies
2.6.1 Flamel Technologies Details
2.6.2 Flamel Technologies Major Business
2.6.3 Flamel Technologies Nano Biotechnology Product and Solutions
2.6.4 Flamel Technologies Recent Developments and Future Plans
2.7 Nanophase Technologies
2.7.1 Nanophase Technologies Details
2.7.2 Nanophase Technologies Major Business
2.7.3 Nanophase Technologies Nano Biotechnology Product and Solutions
2.7.4 Nanophase Technologies Recent Developments and Future Plans
2.8 Sigma Aldrich Company
2.8.1 Sigma Aldrich Company Details
2.8.2 Sigma Aldrich Company Major Business
2.8.3 Sigma Aldrich Company Nano Biotechnology Product and Solutions
2.8.4 Sigma Aldrich Company Recent Developments and Future Plans
2.9 Dendritic Nanotechnologies
2.9.1 Dendritic Nanotechnologies Details
2.9.2 Dendritic Nanotechnologies Major Business
2.9.3 Dendritic Nanotechnologies Nano Biotechnology Product and Solutions
2.9.4 Dendritic Nanotechnologies Recent Developments and Future Plans
2.10 SkyePharma Pharmaceuticals
2.10.1 SkyePharma Pharmaceuticals Details
2.10.2 SkyePharma Pharmaceuticals Major Business
2.10.3 SkyePharma Pharmaceuticals Nano Biotechnology Product and Solutions
2.10.4 SkyePharma Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Nano Biotechnology Revenue and Share by Players (2023 & 2029)
3.2 Nano Biotechnology Players Head Office, Products and Services Provided
3.3 Nano Biotechnology Mergers & Acquisitions
3.4 Nano Biotechnology New Entrants and Expansion Plans

4 Global Nano Biotechnology Forecast by Region
4.1 Global Nano Biotechnology Market Size by Region: 2023 VS 2029
4.2 Global Nano Biotechnology Market Size by Region, (2023-2029)
4.3 North America
4.3.1 Key Companies of Nano Biotechnology in North America
4.3.2 Current Situation and Forecast of Nano Biotechnology in North America
4.3.3 North America Nano Biotechnology Market Size and Prospect (2023-2029)
4.4 Europe
4.4.1 Key Companies of Nano Biotechnology in Europe
4.4.2 Current Situation and Forecast of Nano Biotechnology in Europe
4.4.3 Europe Nano Biotechnology Market Size and Prospect (2023-2029)
4.5 Asia-Pacific
4.5.1 Key Companies of Nano Biotechnology in Asia-Pacific
4.5.2 Current Situation and Forecast of Nano Biotechnology in Asia-Pacific
4.5.3 Asia-Pacific Nano Biotechnology Market Size and Prospect (2023-2029)
4.5.4 China
4.5.5 Japan
4.5.6 South Korea
4.6 South America
4.6.1 Key Companies of Nano Biotechnology in South America
4.6.2 Current Situation and Forecast of Nano Biotechnology in South America
4.6.3 South America Nano Biotechnology Market Size and Prospect (2023-2029)
4.7 Middle East & Africa
4.7.1 Key Companies of Nano Biotechnology in Middle East & Africa
4.7.2 Current Situation and Forecast of Nano Biotechnology in Middle East & Africa
4.7.3 Middle East & Africa Nano Biotechnology Market Size and Prospect (2023-2029)

5 Market Size Segment by Type
5.1 Global Nano Biotechnology Market Forecast by Type (2023-2029)
5.2 Global Nano Biotechnology Market Share Forecast by Type (2023-2029)

6 Market Size Segment by Application
6.1 Global Nano Biotechnology Market Forecast by Application (2023-2029)
6.2 Global Nano Biotechnology Market Share Forecast by Application (2023-2029)

7 Research Findings and Conclusion

8 Appendix
8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Nano Biotechnology Revenue by Type, (USD Million), 2023 VS 2029
Table 2. Global Nano Biotechnology Revenue by Application, (USD Million), 2023 VS 2029
Table 3. Aduro BioTech Corporate Information, Head Office, and Major Competitors
Table 4. Aduro BioTech Major Business
Table 5. Aduro BioTech Nano Biotechnology Product and Solutions
Table 6. Calando Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 7. Calando Pharmaceuticals Major Business
Table 8. Calando Pharmaceuticals Nano Biotechnology Product and Solutions
Table 9. Biosante Phosphate Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 10. Biosante Phosphate Pharmaceuticals Major Business
Table 11. Biosante Phosphate Pharmaceuticals Nano Biotechnology Product and Solutions
Table 12. Celgene Corporation Corporate Information, Head Office, and Major Competitors
Table 13. Celgene Corporation Major Business
Table 14. Celgene Corporation Nano Biotechnology Product and Solutions
Table 15. Elan Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 16. Elan Pharmaceuticals Major Business
Table 17. Elan Pharmaceuticals Nano Biotechnology Product and Solutions
Table 18. Flamel Technologies Corporate Information, Head Office, and Major Competitors
Table 19. Flamel Technologies Major Business
Table 20. Flamel Technologies Nano Biotechnology Product and Solutions
Table 21. Nanophase Technologies Corporate Information, Head Office, and Major Competitors
Table 22. Nanophase Technologies Major Business
Table 23. Nanophase Technologies Nano Biotechnology Product and Solutions
Table 24. Sigma Aldrich Company Corporate Information, Head Office, and Major Competitors
Table 25. Sigma Aldrich Company Major Business
Table 26. Sigma Aldrich Company Nano Biotechnology Product and Solutions
Table 27. Dendritic Nanotechnologies Corporate Information, Head Office, and Major Competitors
Table 28. Dendritic Nanotechnologies Major Business
Table 29. Dendritic Nanotechnologies Nano Biotechnology Product and Solutions
Table 30. SkyePharma Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 31. SkyePharma Pharmaceuticals Major Business
Table 32. SkyePharma Pharmaceuticals Nano Biotechnology Product and Solutions
Table 33. Global Nano Biotechnology Revenue (USD Million) by Players (2023 & 2029)
Table 34. Global Nano Biotechnology Revenue Share by Players (2023 & 2029)
Table 35. Nano Biotechnology Players Head Office, Products and Services Provided
Table 36. Nano Biotechnology Mergers & Acquisitions in the Past Five Years
Table 37. Nano Biotechnology New Entrants and Expansion Plans
Table 38. Global Market Nano Biotechnology Revenue (USD Million) Comparison by Region (2023 VS 2029)
Table 39. Global Nano Biotechnology Revenue Market Share by Region (2023-2029)
Table 40. Key Companies of Nano Biotechnology in North America
Table 41. Current Situation and Forecast of Nano Biotechnology in North America
Table 42. Key Companies of Nano Biotechnology in Europe
Table 43. Current Situation and Forecast of Nano Biotechnology in Europe
Table 44. Key Companies of Nano Biotechnology in Asia-Pacific
Table 45. Current Situation and Forecast of Nano Biotechnology in Asia-Pacific
Table 46. Key Companies of Nano Biotechnology in China
Table 47. Key Companies of Nano Biotechnology in Japan
Table 48. Key Companies of Nano Biotechnology in South Korea
Table 49. Key Companies of Nano Biotechnology in South America
Table 50. Current Situation and Forecast of Nano Biotechnology in South America
Table 51. Key Companies of Nano Biotechnology in Middle East & Africa
Table 52. Current Situation and Forecast of Nano Biotechnology in Middle East & Africa
Table 53. Global Nano Biotechnology Revenue Forecast by Type (2023-2029)
Table 54. Global Nano Biotechnology Revenue Forecast by Application (2023-2029)
List of Figures
Figure 1. Nano Biotechnology Picture
Figure 2. Global Nano Biotechnology Revenue Market Share by Type in 2029
Figure 3. 0-10 nm
Figure 4. 10-100 nm
Figure 5. Nano Biotechnology Revenue Market Share by Application in 2029
Figure 6. Pharmaceuticals Picture
Figure 7. Medical Devices Picture
Figure 8. Medical Research Picture
Figure 9. Other Picture
Figure 10. Global Nano Biotechnology Market Size, (USD Million): 2023 VS 2029
Figure 11. Global Nano Biotechnology Revenue and Forecast (2023-2029) & (USD Million)
Figure 12. Nano Biotechnology Market Drivers
Figure 13. Nano Biotechnology Market Restraints
Figure 14. Nano Biotechnology Market Trends
Figure 15. Aduro BioTech Recent Developments and Future Plans
Figure 16. Calando Pharmaceuticals Recent Developments and Future Plans
Figure 17. Biosante Phosphate Pharmaceuticals Recent Developments and Future Plans
Figure 18. Celgene Corporation Recent Developments and Future Plans
Figure 19. Elan Pharmaceuticals Recent Developments and Future Plans
Figure 20. Flamel Technologies Recent Developments and Future Plans
Figure 21. Nanophase Technologies Recent Developments and Future Plans
Figure 22. Sigma Aldrich Company Recent Developments and Future Plans
Figure 23. Dendritic Nanotechnologies Recent Developments and Future Plans
Figure 24. SkyePharma Pharmaceuticals Recent Developments and Future Plans
Figure 25. Global Nano Biotechnology Revenue Market Share by Region (2023-2029)
Figure 26. Global Nano Biotechnology Revenue Market Share by Region in 2029
Figure 27. North America Nano Biotechnology Revenue (USD Million) and Growth Rate (2023-2029)
Figure 28. Europe Nano Biotechnology Revenue (USD Million) and Growth Rate (2023-2029)
Figure 29. Asia-Pacific Nano Biotechnology Revenue (USD Million) and Growth Rate (2023-2029)
Figure 30. South America Nano Biotechnology Revenue (USD Million) and Growth Rate (2023-2029)
Figure 31. Middle East & Africa Nano Biotechnology Revenue (USD Million) and Growth Rate (2023-2029)
Figure 32. Global Nano Biotechnology Market Share Forecast by Type (2023-2029)
Figure 33. Global Nano Biotechnology Market Share Forecast by Application (2023-2029)
Figure 34. Methodology
Figure 35. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Aduro BioTech
Calando Pharmaceuticals
Biosante Phosphate Pharmaceuticals
Celgene Corporation
Elan Pharmaceuticals
Flamel Technologies
Nanophase Technologies
Sigma Aldrich Company
Dendritic Nanotechnologies
SkyePharma Pharmaceuticals
jiaGou

Add To Cart

gouMai

Buy Now